A mother's fight for her life and the delays that could have changed everything.
Sara Gillooly's story is a powerful reminder of the impact of timely cancer diagnostics. Just weeks after a hysterectomy, Sara discovered a lump in her breast, and her journey into the healthcare system began. The initial response was swift, with a mammogram and scheduled ultrasound and biopsy. However, the pace soon slowed, and the emotional toll mounted.
"It was a very scary moment," Sara recalls, describing the ultrasound where she witnessed the network of veins leading to the tumor. The wait for results and further tests became a full-time battle, one that left her emotionally drained.
But here's where it gets controversial: Sara, a young mother, wanted more. She sought a specific test, the Ki-67 proliferation index, to understand the aggressiveness of her cancer, a test commonly used in the US and Europe. In Canada, this test is less prevalent. She considered traveling to Turkey for quicker access to these tests and treatment.
And this is the part most people miss: the impact of wait times. Sara's cancer metastasized, spreading to her bones and lungs. She wonders if earlier tests could have changed her outcome.
Her friend, MLA Amelia Boultbee, calls the delays "unreasonable," and Sara agrees. She feels the system failed her, despite the kindness of her doctors.
B.C. has recognized the issue, launching a 10-year cancer care plan. But is it enough? With an aging population and successful treatments keeping people in care longer, the strain on the system is immense.
Premier David Eby acknowledges the challenge, promising to drive down testing and treatment times. But for Sara, the damage may already be done.
What do you think? Could earlier intervention have made a difference? Should Canada adopt more aggressive testing protocols? Share your thoughts in the comments.
